See more : HG Holdings, Inc. (STLY) Income Statement Analysis – Financial Results
Complete financial analysis of Well Lead Medical Co., Ltd. (603309.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Well Lead Medical Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- X5 Retail Group N.V. (FIVE.IL) Income Statement Analysis – Financial Results
- MK Seiko Co., Ltd. (5906.T) Income Statement Analysis – Financial Results
- PT Bima Sakti Pertiwi Tbk (PAMG.JK) Income Statement Analysis – Financial Results
- CGift AG (T7RA.HM) Income Statement Analysis – Financial Results
- The Trade Desk, Inc. (TTD) Income Statement Analysis – Financial Results
Well Lead Medical Co., Ltd. (603309.SS)
About Well Lead Medical Co., Ltd.
Well Lead Medical Co., Ltd. engages in the research, production, and sale of medical catheters in anaesthesia, urology, respiratory, and hemodialysis areas. It also provides drainage suction nutrition products. Its products are used in hospitals, in division operations, therapies, and emergency and clinical care areas. The company markets and sells its products in China, North America, Europe, and Japan. Well Lead Medical Co., Ltd. was founded in 2004 and is headquartered in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37B | 1.36B | 1.12B | 1.13B | 993.81M | 745.83M | 629.89M | 515.42M | 548.87M | 496.41M | 437.17M | 387.22M | 348.24M |
| Cost of Revenue | 750.92M | 774.50M | 644.73M | 635.95M | 554.09M | 483.54M | 414.80M | 322.65M | 365.40M | 317.55M | 277.35M | 250.02M | 236.28M |
| Gross Profit | 621.00M | 588.86M | 473.84M | 494.73M | 439.72M | 262.30M | 215.10M | 192.77M | 183.47M | 178.87M | 159.82M | 137.20M | 111.95M |
| Gross Profit Ratio | 45.27% | 43.19% | 42.36% | 43.75% | 44.25% | 35.17% | 34.15% | 37.40% | 33.43% | 36.03% | 36.56% | 35.43% | 32.15% |
| Research & Development | 94.92M | 82.07M | 55.03M | 55.31M | 42.25M | 16.74M | 12.00M | 9.72M | 5.70M | 4.58M | 2.51M | 801.81K | 0.00 |
| General & Administrative | 36.58M | 27.19M | 26.43M | 22.95M | 25.75M | 25.24M | 18.11M | 15.45M | 15.62M | 9.93M | 10.40M | 9.41M | 29.31M |
| Selling & Marketing | 61.55M | 156.02M | 142.94M | 97.24M | 123.15M | 74.04M | 53.38M | 46.81M | 36.82M | 30.45M | 27.77M | 26.94M | 18.34M |
| SG&A | 292.85M | 183.21M | 169.37M | 120.19M | 148.89M | 99.28M | 71.49M | 62.26M | 52.44M | 40.39M | 38.17M | 36.35M | 47.65M |
| Other Expenses | -1.51M | 107.99M | 88.59M | 88.14M | 86.97M | -1.02M | 393.87K | 10.27M | 3.40M | 990.66K | 1.44M | 2.34M | 152.87K |
| Operating Expenses | 386.26M | 373.28M | 312.99M | 263.64M | 278.12M | 195.27M | 139.72M | 123.88M | 104.21M | 87.21M | 77.93M | 66.85M | 51.25M |
| Cost & Expenses | 1.15B | 1.15B | 957.72M | 899.60M | 832.21M | 678.81M | 554.52M | 446.53M | 469.62M | 404.76M | 355.27M | 316.87M | 287.53M |
| Interest Income | 3.67M | 3.48M | 1.38M | 904.45K | 607.14K | 544.89K | 386.79K | 547.30K | 1.12M | 132.44K | 150.94K | 265.52K | -0.42 |
| Interest Expense | 9.12M | 7.87M | 8.49M | 10.43M | 13.57M | 3.10M | 7.82M | 0.00 | 586.83K | 3.50M | 1.77M | 2.74M | 2.14M |
| Depreciation & Amortization | 72.62M | 65.75M | 57.05M | 49.65M | 43.27M | 29.60M | 21.60M | 18.92M | 16.96M | 14.77M | 11.56M | 10.72M | 1.68M |
| EBITDA | 317.19M | 285.15M | 204.56M | 250.79M | 206.97M | 105.77M | 97.33M | 114.60M | 118.78M | 105.39M | 91.29M | 79.44M | 60.71M |
| EBITDA Ratio | 23.12% | 21.61% | 19.13% | 23.15% | 21.92% | 13.62% | 15.81% | 22.39% | 21.62% | 21.61% | 20.81% | 21.48% | 17.37% |
| Operating Income | 238.84M | 206.65M | 142.72M | 198.27M | 146.85M | 69.63M | 72.34M | 85.25M | 97.37M | 86.15M | 76.68M | 65.73M | 58.80M |
| Operating Income Ratio | 17.41% | 15.16% | 12.76% | 17.54% | 14.78% | 9.34% | 11.48% | 16.54% | 17.74% | 17.35% | 17.54% | 16.97% | 16.89% |
| Total Other Income/Expenses | -1.54M | -1.00M | -2.50M | -8.16M | 882.19K | -1.02M | 393.88K | 10.05M | 3.22M | 964.30K | 1.28M | -681.02K | 145.12K |
| Income Before Tax | 237.30M | 205.65M | 140.22M | 190.11M | 147.73M | 68.60M | 72.73M | 95.21M | 100.59M | 87.11M | 77.96M | 68.03M | 58.95M |
| Income Before Tax Ratio | 17.30% | 15.08% | 12.54% | 16.81% | 14.87% | 9.20% | 11.55% | 18.47% | 18.33% | 17.55% | 17.83% | 17.57% | 16.93% |
| Income Tax Expense | 32.70M | 27.90M | 25.55M | 30.23M | 23.24M | 12.16M | 12.47M | 16.55M | 9.27M | 19.30M | 14.46M | 12.77M | 9.60M |
| Net Income | 192.49M | 166.57M | 106.09M | 153.11M | 121.14M | 65.40M | 64.56M | 79.25M | 91.32M | 67.82M | 63.59M | 55.61M | 47.92M |
| Net Income Ratio | 14.03% | 12.22% | 9.48% | 13.54% | 12.19% | 8.77% | 10.25% | 15.38% | 16.64% | 13.66% | 14.54% | 14.36% | 13.76% |
| EPS | 0.66 | 0.58 | 0.41 | 0.59 | 0.47 | 0.25 | 0.25 | 0.31 | 0.37 | 0.35 | 0.33 | 0.28 | 0.25 |
| EPS Diluted | 0.66 | 0.58 | 0.41 | 0.59 | 0.47 | 0.25 | 0.25 | 0.31 | 0.37 | 0.35 | 0.33 | 0.28 | 0.25 |
| Weighted Avg Shares Out | 291.64M | 289.63M | 260.00M | 260.00M | 260.00M | 257.65M | 260.00M | 257.56M | 247.34M | 195.90M | 194.50M | 195.38M | 195.38M |
| Weighted Avg Shares Out (Dil) | 291.64M | 289.63M | 260.00M | 260.00M | 260.00M | 257.65M | 262.26M | 257.56M | 247.34M | 195.92M | 194.50M | 195.38M | 195.38M |
Source: https://incomestatements.info
Category: Stock Reports